Postdoctoral Scientist Opportunity in Next-Generation Blood Cancer Immunotherapy at the University of Southampton
Are you a driven and innovative postdoctoral scientist passionate about making a tangible impact on the lives of patients battling acute myeloid leukaemia (AML)? The University of Southampton presents an exceptional opportunity to join a dynamic research team and contribute to a cutting-edge, Blood Cancer UK-funded programme dedicated to developing novel, off-the-shelf immunotherapies.
This three-year project, led by the esteemed laboratories of Dr. Salah Mansour and Dr. Ali Roghanian, focuses on harnessing the power of cytotoxic invariant Natural Killer T (iNKT) cells for the precise targeting of AML. This aggressive leukaemia presents a significant challenge with limited survival outcomes, making advancements in treatment critically important. Building on robust preliminary data, this role offers a unique chance to bridge the gap between fundamental and translational immunology, utilizing bespoke in vivo models to identify and exploit therapeutically relevant iNKT cell subsets.
As a Postdoctoral Scientist, you will be at the forefront of scientific discovery, leading critical studies on cytotoxic T cell mechanisms, overseeing preclinical validation, and advancing CAR-iNKT platforms specifically optimized for AML immunotherapy. This multidisciplinary role invites creative thinkers with a strong interest in tumour immunology, T cell engineering, and immunotherapy. You will collaborate with a diverse team encompassing immunology and bioinformatics experts, with access to state-of-the-art facilities including advanced flow cytometry, 10X Genomics, and in vivo imaging platforms.
Key Advantages for Your Career Path:
Key Responsibilities Include:
Essential Qualifications and Experience:
Desirable Skills and Experience:
Considerations for Aspiring Candidates:
This role is ideal for a scientist who thrives in a collaborative and intellectually stimulating environment. If you are looking to build a career at the intersection of immunology, cancer biology, and immunotherapy, this position offers a significant platform for growth. The opportunity to work on a project with direct translational potential for a significant unmet medical need should be a key motivator for candidates seeking to make a real-world impact. The University of Southampton's commitment to translational research and its strong connections with clinical and industry partners provide a robust framework for career development and future opportunities.
The start date is flexible, with November 2025 or soon after being ideal. Applicants nearing PhD completion will be considered, with the title of Senior Research Assistant awarded prior to PhD conferral and transitioning to Research Fellow upon successful defence.